Unusual 11 Mid-Day Movers 11/23: ABIO, SEED, FNET, CDTI Higher; ...

Courtesy StreetInsider.com News Articles  Mon, 11/23/2009 - 11:55

ARCA Biopharma, Inc. (NASDAQ: ABIO) 89.3% HIGHER; today announced that the U.S. FDA has designated as a Fast Track development program the investigation of Gencaro, the Company's investigational, pharmacologically unique beta-blocker and mild vasodilator, for the reduction of cardiovascular mortality and cardiovascular hospitalizations in a genotype-defined heart failure population.

The Company intends to submit a study protocol for review under the FDA's Special Protocol Assessment process for the design of a clinical trial to assess the safety and efficacy of...


 

Related items

Morning Movers 11/23: ABIO, SEED, FIF, FNET, DDRX,...
ARCA Biopharma, Inc. (NASDAQ: ABIO) 47.6% HIGHER; today announced that the U.S. FDA has designated as a Fast Track development program the investigation of Gencaro, the Company's...

Merck's heart failure drug misses trial goals
Merck says its heart failure treatment rolofylline missed its goals in a trial, failing to improve patient symptoms compared with a placebo.

Unusual 11 Mid-Day Movers 6/1: FEP, PMI, GPRE, ETWC...
Franklin Electronic Publishers, Inc. (AMEX: FEP) 111% HIGHER; today announced that it has received a copy of a Schedule 13D filed with the SEC relating to a non-binding proposal by Saunders...

AT&T 5800 Accessory Handset for 5800 Series Phones
Advanced American Telephones designs and produces the telephone products that millions of people enjoy every day. AT&T's voice quality, product selection, and reliability make these telephone...

Iris USOA447 IRIScan Express 2 Portable Scanner
Scan Anywhere. Get Organized! The IRIScan Express 2 is ultra portable, and backed by a powerful software suite, so you can get things done! Scan your documents, receipts, business cards,...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
CAPTCHA
We apologize for the inconvenience. Please help fight spam.
business.marc8.com